10x Genomics (TXG) Invested Capital (2018 - 2019)

10x Genomics (TXG) reported Invested Capital of $9.9 million for Q4 2019, up 136.02% on a YoY basis from $4.2 million in Q4 2018, and up 33.85% sequentially from $7.4 million in Q3 2019.

10x Genomics (TXG) Invested Capital (2018 - 2019) Analysis & Trends

10x Genomics (TXG) has 2 years of Invested Capital data on file, last reported at $9.9 million in Q4 2019.

  • For the quarter ending Q4 2019, Invested Capital rose 136.02% year-over-year to $9.9 million; the trailing twelve-month figure through Sep 2020 stood at $9.9 million (down 14.59% YoY), and the FY2019 full-year result was $9.9 million, up 136.02% from the prior year.
  • Invested Capital climbed to $9.9 million in Q4 2019, from $7.4 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $9.9 million in Q4 2019 to a low of $4.2 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn -
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn 52.96 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn -
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn -
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn -
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn -
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn 14.19 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn -
9 Privia Health 3.10 Bn 2.73 Bn - -
10 Omnicell 1.81 Bn 1.57 Bn 140.36 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 9.88 Mn
Sep 30, 2019 7.38 Mn
Dec 31, 2018 4.19 Mn